Protocol Ledger

NCT06226805 · Phase II · RECRUITING

Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)

Interventional Phase II clinical trial protocol NCT06226805 sponsored by Basking Biosciences in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-07-31 Enrollment: 228 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06226805
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)228 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06226805
Protocol FieldVerified Registry Value
NCT IdentifierNCT06226805
Consolidated Lead SponsorBasking Biosciences
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment228 participants (ESTIMATED)
Registered Start Date2024-07-31
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI